Condition
Gaucher Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Gaucher Disease clinical trials that are recruiting, at sites in 38 countries (most in United States (5), Argentina (2), Israel (2)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 38Countries
Newest Gaucher Disease clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Gaucher Disease: Following Patients on Standard Care to See How It Progresses | — | New Haven, Connecticut | Recruiting | Aug 11, 2026 |
| Registry for Rare Diseases | — | Buenos Aires, Buenos Aires | Recruiting | Aug 27, 2024 |
| Prevalence of Acid Sphingomyelinase Deficiency and Gaucher Disease in Patients with Monoclonal Gammopathies | — | Vitoria-Gasteiz, Alava and 22 other locations | Recruiting | Aug 15, 2023 |
| Exploring extracellular vesicles in Gaucher Disease | — | Minneapolis, Minnesota | Recruiting | May 6, 2023 |
| Ambroxol for people with Gaucher disease or GBA-related Parkinson's disease | — | Jerusalem, Please Select... and 2 other locations | Recruiting | May 15, 2020 |
| Long-term observation of rare genetic brain disorders | — | Pittsburgh, Pennsylvania | Recruiting | Nov 6, 2017 |
| Registry for patients with Gaucher Disease | — | Lexington, Massachusetts | Recruiting | Sep 25, 2017 |
| Long-term follow-up for Gaucher disease | — | Durham, North Carolina | Recruiting | Jun 19, 2017 |
| Registry tracking outcomes for patients with Gaucher disease | — | Phoenix, Arizona and 316 other locations | Recruiting | Aug 1, 2006 |
All recruiting trials (9)
-
Gaucher Disease: Following Patients on Standard Care to See How It Progresses
This study will observe people with Gaucher disease who are receiving standard care to see how their condition changes over time and to explore the biology behind persistent or worsening disease.
-
Registry for Rare Diseases
This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.
-
Prevalence of Acid Sphingomyelinase Deficiency and Gaucher Disease in Patients with Monoclonal Gammopathies
This study is trying to see how common Acid Sphingomyelinase Deficiency and Gaucher Disease are in patients with monoclonal gammopathies, especially those with an enlarged spleen or who have had their spleen removed.
-
Exploring extracellular vesicles in Gaucher Disease
This study is trying to see how certain tiny particles in the body behave differently in people with Gaucher Disease compared to healthy individuals to understand their role in communication between cells and possible links to brain inflammation.
-
Ambroxol for people with Gaucher disease or GBA-related Parkinson's disease
This project tests whether ambroxol is safe and may help people with Gaucher disease or Parkinson's disease caused by GBA gene changes.
-
Long-term observation of rare genetic brain disorders
This study is tracking how rare genetic brain disorders progress over time to better understand their effects on patients.
-
Registry for patients with Gaucher Disease
This study is collecting information from people with Gaucher Disease to see how well different treatments work and to learn more about the disease over time.
-
Long-term follow-up for Gaucher disease
This study looks at how well enzyme replacement therapy and substrate reduction therapy work for people with Gaucher disease over the long term by tracking their health records.
-
Registry tracking outcomes for patients with Gaucher disease
This study tracks the health and progress of people with Gaucher disease to help improve treatment and care for them, including those who are pregnant.
Related topics
Quick answers
How many Gaucher Disease clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 38 countries. The most sites are in United States (5 trials), Argentina (2 trials), Israel (2 trials), Australia (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.